Many viruses evade host defense mechanisms by targeting specific host vulnerabilities, revealing critical points in host pathways regulating antiviral responses. Recent advances in our understanding of how influenza virus escapes host countermeasures have exposed novel mechanisms of virulence that can be exploited pharmacologically. The NS1 protein of influenza virus, a major virulence factor, inhibits host gene expression and signal transduction required to mount innate and adaptive immune responses. In infected cells, NS1 is localized in the nucleus and the cytoplasm. Based on the function of NS1 as inhibitor of gene expression, we performed a high throughput screen (HTS) of 200,000 synthetic chemical compounds and identified novel inhibitors of NS1. We selected eight classes of novel compounds that significantly restored gene expression in the presence of NS1, and that also inhibited both influenza virus replication and host cell death. We propose that antagonists of either nuclear and/or cytoplasmic activities of NS1 will be novel inhibitors of viral replication and pathogenesis. We will combine chemical biology, cell biology, and virology to investigate the mechanisms by which the compounds we have identified inhibit influenza virus replication. We will characterize two families of small molecules that can serve as leads for molecular therapy. In addition, the proposed studies will provide new insights into mechanisms by which influenza virus evades host defense pathways that can be further targeted pharmacologically. We will pursue the following aims:
Aim 1. To investigate structure-activity relationship (SAR) of NS1 inhibitors.
Aim 2. To determine the activity of NS1 inhibitors on Antiviral Responses in vivo.
Aim 3. To identify targeted pathways and mechanisms of action of compounds which inhibit NS1 function. In sum, these studies will likely reveal novel leads for antiviral therapies as well as provide information on novel mechanisms of viral-host interactions and pathways.

Public Health Relevance

Novel therapeutics to prevent viral disease in humans are needed because viruses become resistant to currently used drugs and it is difficult to protect the entire population by vaccination. This project will develop new classes of chemical compounds capable of inhibiting the growth of influenza virus and other viruses to the stage where they can be shown to prevent viral disease in animal models, the first step towards developing leads to new antiviral therapeutics for humans.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI079110-04
Application #
8510550
Study Section
Drug Discovery and Mechanisms of Antimicrobial Resistance Study Section (DDR)
Program Officer
Krafft, Amy
Project Start
2010-06-15
Project End
2015-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
4
Fiscal Year
2013
Total Cost
$369,914
Indirect Cost
$137,264
Name
University of Texas Sw Medical Center Dallas
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Yarbrough, Melanie L; Zhang, Ke; Sakthivel, Ramanavelan et al. (2014) Primate-specific miR-576-3p sets host defense signalling threshold. Nat Commun 5:4963
Mor, Amir; White, Michael A; Fontoura, Beatriz M A (2014) Nuclear trafficking in health and disease. Curr Opin Cell Biol 28:28-35
Yarbrough, Melanie L; Mata, Miguel A; Sakthivel, Ramanavelan et al. (2014) Viral subversion of nucleocytoplasmic trafficking. Traffic 15:127-40
Tsai, Pei-Ling; Chiou, Ni-Ting; Kuss, Sharon et al. (2013) Cellular RNA binding proteins NS1-BP and hnRNP K regulate influenza A virus RNA splicing. PLoS Pathog 9:e1003460
Kuss, Sharon K; Mata, Miguel A; Zhang, Liang et al. (2013) Nuclear imprisonment: viral strategies to arrest host mRNA nuclear export. Viruses 5:1824-49
Das, Priyabrata; Deng, Xiaoyi; Zhang, Liang et al. (2013) SAR Based Optimization of a 4-Quinoline Carboxylic Acid Analog with Potent Anti-Viral Activity. ACS Med Chem Lett 4:517-521
Zhang, Liang; Das, Priyabrata; Schmolke, Mirco et al. (2012) Inhibition of pyrimidine synthesis reverses viral virulence factor-mediated block of mRNA nuclear export. J Cell Biol 196:315-26
Zhang, Zi Chao; Satterly, Neal; Fontoura, Beatriz M A et al. (2011) Evolutionary development of redundant nuclear localization signals in the mRNA export factor NXF1. Mol Biol Cell 22:4657-68
Mata, Miguel A; Satterly, Neal; Versteeg, Gijs A et al. (2011) Chemical inhibition of RNA viruses reveals REDD1 as a host defense factor. Nat Chem Biol 7:712-9